What is BeatO App?
Founded in 2015 and headquartered in New Delhi, BeatO App provides a comprehensive digital health platform designed to empower patients to manage diabetes effectively. The company distinguishes itself through its innovative, compact smartphone glucometers that provide accurate, real-time data, which is then synchronized with a mobile application to track blood glucose levels, physical activity, and caloric intake. By integrating hardware with a user-centric software interface, BeatO App addresses the critical need for accessible, data-driven healthcare solutions. Its market position is defined by its ability to transform routine medical monitoring into a seamless, actionable experience for users, effectively positioning the firm as a leader in the Indian health-tech sector.
How much funding has BeatO App raised?
BeatO App has raised a total of $38.6M across 2 funding rounds:
Other Financing Round
$5.6M
Series B
$33M
Other Financing Round (2021): $5.6M with participation from Pharmeasy, Leo Capital, Merisis VP, Orios Venture Partners, and W Health Ventures
Series B (2022): $33M led by Flipkart, HealthQuad, and Lightrock India
Key Investors in BeatO App
HealthQuad
HealthQuad is a prominent healthcare innovation fund in India that invests across the value chain to improve quality of care and disease prevention.
Orios Venture Partners
Orios Venture Partners is an early-stage VC firm that provides strategic support to technology-driven startups across B2C and B2B sectors.
Leo Capital
Leo Capital is a venture capital fund specializing in early-stage, technology-centric opportunities with a focus on scalable business models in India.
What's next for BeatO App?
With the recent influx of capital, BeatO App is well-positioned to scale its operations and deepen its penetration into the broader healthcare value chain. The strategic focus will likely shift toward enhancing its diagnostic capabilities, expanding its service offerings, and strengthening its enterprise-level partnerships. As the company matures, the emphasis will remain on leveraging technology to improve clinical outcomes and operational efficiency. By continuing to attract institutional backing from firms focused on healthcare innovation, BeatO App is poised to set new benchmarks for chronic disease management, potentially exploring further integration with broader health ecosystems and digital pharmacy networks to provide a holistic patient experience.
See full BeatO App company page
